{
    "address": "Flojelbergsgatan 8C, Molndal",
    "city": "Goeteborg",
    "country": "SE",
    "currency": "SEK",
    "cusip": "W3R32E101",
    "description": "Fluicell AB engages in the provision of fluid platforms for multi-functional pipettes for cell-based pharmacology research. The company is headquartered in Goeteborg, Vastra Gotalands. The company went IPO on 2018-04-18. The company commercializes a product portfolio for processing and studying of individual cells, primarily in the field of drug development. The Company\u2019s products comprise research tools BioPen and Dynaflow Resolve. Tools enable researchers to study, process and measure drug impact on individual cells. Also, the Company develops bioprinting technology Biopixlar Retina in both two-dimensional (2D) and three-dimensional (3D) options. Biopixlar Retina creates complex tissue-like structures with control over positioning of individual cells.",
    "employeeTotal": "",
    "exchange": "NASDAQ OMX NORDIC",
    "finnhubIndustry": "Health Care",
    "ggroup": "Health Care Equipment & Services",
    "gind": "Health Care Equipment & Supplies",
    "gsector": "Health Care",
    "gsubind": "Health Care Equipment",
    "ipo": "2018-04-18",
    "isin": "SE0010831321",
    "logo": "https://finnhub.io/api/logo?symbol=FLUI.ST",
    "marketCapitalization": 257.8116,
    "naics": "Scientific Research and Development Services",
    "naicsNationalIndustry": "Research and Development in Biotechnology",
    "naicsSector": "Professional, Scientific, and Technical Services",
    "naicsSubsector": "Professional, Scientific, and Technical Services",
    "name": "Fluicell AB",
    "phone": "46762083354.0",
    "sedol": "BF3SZ11",
    "shareOutstanding": 11.991239,
    "state": "VASTRA GOTALANDS",
    "ticker": "FLUI.ST",
    "weburl": "http://fluicell.com/"
}